中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2013年
3期
528-529
,共2页
输血前%受血者%抗-TP%抗-HIV1/2%HBSAg%抗-HCV%检测%临床意义
輸血前%受血者%抗-TP%抗-HIV1/2%HBSAg%抗-HCV%檢測%臨床意義
수혈전%수혈자%항-TP%항-HIV1/2%HBSAg%항-HCV%검측%림상의의
Before blood transfusion, Donee%Anti-TP%Anti-HIV1/2%HBSAg%Anti-HCV%Detection%Clinical significance
目的:探讨输血前对受血者四项感染性疾病指标的检测及临床意义.方法:本院2011年1月~2012年12月需要输血治疗的患者820例,分别在受血前进行梅毒螺旋体抗体(抗-TP)、人类免疫缺陷病毒抗体(抗-HIV1/2)、乙型肝炎表面抗原(HBSAg)、丙型肝炎病毒抗体(抗-HCV)四项感染性疾病指标检测,探讨受血前上述指标检测的临床意义.结果:抗-TP阳性9例,阳性率为1.10%;抗-HIV1/2阳性1例,阳性率为0.12%;HBSAg阳性65例,阳性率为7.93%;抗-HCV阳性5例,阳性率为0.61%;其中男性阳性患者56例,阳性率为13.59%;女性阳性患者24例,阳性率为5.97%;男性感染性疾病患者明显高于女性,两种性别比较差异具有显著性,有统计学意义P<0.05.结论:输血前对受血者抗-TP、抗-HIV1/2、HBSAg、抗-HCV四项感染性疾病指标的检测可以确定患者受血前是否患有以上四种与输血相关的传染性疾病,避免输血后不必要的医疗纠纷,同时可及时发现潜在的感染源,并进行预见性的管理,对降低医院感染率具有重要意义.
目的:探討輸血前對受血者四項感染性疾病指標的檢測及臨床意義.方法:本院2011年1月~2012年12月需要輸血治療的患者820例,分彆在受血前進行梅毒螺鏇體抗體(抗-TP)、人類免疫缺陷病毒抗體(抗-HIV1/2)、乙型肝炎錶麵抗原(HBSAg)、丙型肝炎病毒抗體(抗-HCV)四項感染性疾病指標檢測,探討受血前上述指標檢測的臨床意義.結果:抗-TP暘性9例,暘性率為1.10%;抗-HIV1/2暘性1例,暘性率為0.12%;HBSAg暘性65例,暘性率為7.93%;抗-HCV暘性5例,暘性率為0.61%;其中男性暘性患者56例,暘性率為13.59%;女性暘性患者24例,暘性率為5.97%;男性感染性疾病患者明顯高于女性,兩種性彆比較差異具有顯著性,有統計學意義P<0.05.結論:輸血前對受血者抗-TP、抗-HIV1/2、HBSAg、抗-HCV四項感染性疾病指標的檢測可以確定患者受血前是否患有以上四種與輸血相關的傳染性疾病,避免輸血後不必要的醫療糾紛,同時可及時髮現潛在的感染源,併進行預見性的管理,對降低醫院感染率具有重要意義.
목적:탐토수혈전대수혈자사항감염성질병지표적검측급림상의의.방법:본원2011년1월~2012년12월수요수혈치료적환자820례,분별재수혈전진행매독라선체항체(항-TP)、인류면역결함병독항체(항-HIV1/2)、을형간염표면항원(HBSAg)、병형간염병독항체(항-HCV)사항감염성질병지표검측,탐토수혈전상술지표검측적림상의의.결과:항-TP양성9례,양성솔위1.10%;항-HIV1/2양성1례,양성솔위0.12%;HBSAg양성65례,양성솔위7.93%;항-HCV양성5례,양성솔위0.61%;기중남성양성환자56례,양성솔위13.59%;녀성양성환자24례,양성솔위5.97%;남성감염성질병환자명현고우녀성,량충성별비교차이구유현저성,유통계학의의P<0.05.결론:수혈전대수혈자항-TP、항-HIV1/2、HBSAg、항-HCV사항감염성질병지표적검측가이학정환자수혈전시부환유이상사충여수혈상관적전염성질병,피면수혈후불필요적의료규분,동시가급시발현잠재적감염원,병진행예견성적관리,대강저의원감염솔구유중요의의.
@@@@Objective:To study the blood transfusion before receptor four infectious disease index test and clinical significance. Methods:Our hospital in January 2011~December 2012 need a blood transfusion treatment of 820 cases of patients, respectively, by the blood in before treponema pallidum antibody (anti-TP), human immunodeficiency virus antibody (anti-HIV1/2), and hepatitis b surface antigen (HBSAg), hepatitis c virus antibody (anti-HCV) four infectious disease index detection, this paper discusses the above index by blood before the clinical significance of detection. Results:The anti-TP positive 9 cases, positive rate is 1.10%;Anti-HIV1/2 positive 1 example, positive rate is 0.12%;HBSAg positive 65 example, positive rate is 7.93%;Anti-HCV positive in 5 cases, positive rate is 0.61%;The male patients with positive 56 patients, positive rate is 13.59%;Female positive patients, 24 cases were positive rate is 5.97%;The male patients with infectious diseases significantly higher than female, two kinds of sex compared with significant difference, there is statistical significance (P<0.05). Conclusion:Before blood transfusion of blood donors by anti-TP, anti-HIV1/2, HBSAg, anti-HCV four infectious disease index test can determine whether patients with blood by before with the above four and blood transfusion related infectious diseases, to avoid unnecessary after blood transfusion of medical dispute, at the same time can timely find potential source of infection, and predictive management, to reduce hospital infection rate has important significance.
